PET/CT评估高危子宫内膜癌腹膜后淋巴结转移的价值:ACRIN 6671/GOG 0233试验结果
该前瞻性多中心研究评估了氟18脱氧葡萄糖(FDG)PET联合增强CT诊断高危子宫内膜癌淋巴结转移的准确性。207例患者接受PET/CT及盆腔和腹部淋巴结清扫术。与单独诊断性CT相比,PET/CT在腹部和盆腔均显著提高敏感度(腹部0.65 vs 0.50,P=0.01;盆腔0.65 vs 0.48,P=0.004),同时保持高特异度。
要点
- PET/CT对腹部淋巴结转移敏感度0.65,显著高于诊断性CT的0.50(P=0.01)。
- PET/CT对盆腔淋巴结转移敏感度0.65,显著高于诊断性CT的0.48(P=0.004)。
- PET/CT与诊断性CT的特异度在腹部和盆腔均无显著差异。
核心结论
- FDG PET/CT对高危子宫内膜癌腹部淋巴结转移具有满意的诊断准确性;与单独诊断性CT相比,联合PET在腹部和盆腔均显著提高敏感度,同时保持高特异度。
研究设计与样本
- 前瞻性多中心研究(ACRIN 6671/GOG 0233),符合HIPAA,获机构审查委员会批准,所有参与者签署书面知情同意;数据采集于2010年1月至2013年6月;215例入组患者中207例有PET/CT和腹部及盆腔病理检查结果,平均年龄62.7岁±9.6(标准差);中央阅片研究纳入全部23例腹部检查阳性患者和26例随机选取的腹部检查阴性患者;7名独立盲法阅片者间隔1个月在不同场次分别判读诊断性CT和PET/CT结果;以患者为单位,将腹部(左右腹主动脉旁和髂总)和盆腔(左右髂外和闭孔)淋巴结区域与病理结果按侧别对应计算准确性;效能计算针对腹部敏感度和特异度。
诊断标准与关键数值
- 腹部淋巴结转移:PET/CT敏感度0.65(95%CI:0.57,0.72)vs 诊断性CT 0.50(95%CI:0.43,0.58),P=0.01。
- 盆腔淋巴结转移:PET/CT敏感度0.65(95%CI:0.57,0.72)vs 诊断性CT 0.48(95%CI:0.41,0.56),P=0.004。
- 腹部特异度:PET/CT 0.88(95%CI:0.83,0.92)vs 诊断性CT 0.93(95%CI:0.89,0.96),P=0.11。
- 盆腔特异度:PET/CT 0.93(95%CI:0.86,0.96)vs 诊断性CT 0.89(95%CI:0.82,0.94),P=0.27。
- 腹部AUC:PET/CT 0.78(95%CI:0.66,0.89)vs 诊断性CT 0.74(95%CI:0.63,0.86),P=0.39;盆腔AUC:PET/CT 0.82(95%CI:0.71,0.92)vs 诊断性CT 0.73(95%CI:0.63,0.84),P=0.02。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To assess the diagnostic accuracy of fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with diagnostic contrast material-enhanced computed tomography (CT) in detecting lymph node (LN) metastasis in high-risk endometrial cancer. Materials and Methods This prospective multicenter HIPAA-compliant study had institutional review board approval, and all participants gave written informed consent. Data were accrued between January 2010 and June 2013. Patients underwent PET/CT and pelvic and abdominal lymphadenectomy. Two hundred seven of 215 enrolled patients had PET/CT and pathologic examination results for the abdomen and pelvis. Mean patient age was 62.7 years ± 9.6 (standard deviation). Data in all 23 patients with a positive abdominal examination and in 26 randomly selected patients with a negative abdominal examination were used for this central reader study. Seven independent blinded readers reviewed diagnostic CT and PET/CT results in different sessions 1 month apart. Accuracy was calculated at the participant level, correlating abdominal (right and left para-aortic and common iliac) and pelvic (right and left external iliac and obturator) LN regions with pathologic results, respecting laterality. Reader-average sensitivities, specificities, and areas under the receiver operating characteristic curve (AUCs) of PET/CT and diagnostic CT were compared. Power calculation was for sensitivity and specificity in the abdomen. Results Sensitivities of PET/CT versus diagnostic CT for the detection of LN metastasis were 0.65 (95% confidence interval [CI]: 0.57, 0.72) versus 0.50 (95% CI: 0.43, 0.58) (P = .01) in the abdomen and 0.65 (95% CI: 0.57, 0.72) versus 0.48 (95% CI: 0.41, 0.56) (P = .004) in the pelvis. Corresponding specificities were 0.88 (95% CI: 0.83, 0.92) versus 0.93 (95% CI: 0.89, 0.96) (P = .11) and 0.93 (95% CI: 0.86, 0.96) versus 0.89 (95% CI: 0.82, 0.94) (P = .27), and AUCs were 0.78 (95% CI: 0.66, 0.89) versus 0.74 (95% CI: 0.63, 0.86) (P = .39) and 0.82 (95% CI: 0.71, 0.92) versus 0.73 (95% CI: 0.63, 0.84) (P = .02). Conclusion FDG PET/CT has satisfactory diagnostic accuracy in the detection of abdominal LN metastasis in high-risk endometrial cancer. Compared with diagnostic CT alone, addition of PET to diagnostic CT significantly increased sensitivity in both the abdomen and pelvis while maintaining high specificity. © RSNA, 2017 Online supplemental material is available for this article.
引用
- Atri M, Zhang Z, Dehdashti F, et al. Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial. Radiology. 2017. PMID: 28051912. doi:10.1148/radiol.2016160200
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。